324 related articles for article (PubMed ID: 24958232)
41. Atypical Fibroxanthoma.
Chapman LW; Yu SS; Arron ST
Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
[TBL] [Abstract][Full Text] [Related]
42. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
[TBL] [Abstract][Full Text] [Related]
43. Clear cell atypical fibroxanthoma: a case report and review of the literature.
Nguyen CM; Chong K; Cassarino D
J Cutan Pathol; 2016 Jun; 43(6):538-542. PubMed ID: 26956561
[TBL] [Abstract][Full Text] [Related]
44. Atypical fibroxanthoma in a young female misdiagnosed clinically as a malignant melanoma--An unusual presentation.
Pujani M; Hassan MJ; Jetley S
J Cancer Res Ther; 2015; 11(4):1027. PubMed ID: 26881598
[TBL] [Abstract][Full Text] [Related]
45. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
46. Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
Dei Tos AP; Maestro R; Doglioni C; Gasparotto D; Boiocchi M; Laurino L; Fletcher CD
Am J Pathol; 1994 Jul; 145(1):11-7. PubMed ID: 8030743
[TBL] [Abstract][Full Text] [Related]
47. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
[TBL] [Abstract][Full Text] [Related]
48. Atypical fibroxanthoma: a review of the literature.
Iorizzo LJ; Brown MD
Dermatol Surg; 2011 Feb; 37(2):146-57. PubMed ID: 21269345
[TBL] [Abstract][Full Text] [Related]
49. Atypical fibroxanthoma in the setting of chronic lymphocytic leukemia and other non-Hodgkin lymphomas.
Colgan MB; Brewer JD; Weaver AL; Roenigk RK; Otley CC
Dermatol Surg; 2011 May; 37(5):671-6. PubMed ID: 21446993
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Helbig D; Mauch C; Buettner R; Quaas A
J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis: atypical fibroxanthoma or not? Evaluating spindle cell malignancies on sun damaged skin: a practical approach.
Heintz PW; White CR
Semin Cutan Med Surg; 1999 Mar; 18(1):78-83. PubMed ID: 10188846
[TBL] [Abstract][Full Text] [Related]
52. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
53. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
54. Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
Hollmig ST; Rieger KE; Henderson MT; West RB; Sundram UN
Am J Dermatopathol; 2013 Apr; 35(2):176-9. PubMed ID: 23000905
[TBL] [Abstract][Full Text] [Related]
55. [Atypical fibroxanthoma and pleomorphic dermal sarcoma].
Ziemer M; Jäger IM; Dippel E
Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069
[TBL] [Abstract][Full Text] [Related]
56. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC; Keenan M; Lazova R
Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
[TBL] [Abstract][Full Text] [Related]
57. Melanoma mimicking atypical fibroxanthoma: Report of an unusual case.
Wang Y; Guo Y
J Cutan Pathol; 2021 Dec; 48(12):1493-1496. PubMed ID: 34258786
[TBL] [Abstract][Full Text] [Related]
58. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
59. Ultrastructure of spindle cell squamous carcinoma.
Feldman PS; Barr RJ
J Cutan Pathol; 1976; 3(1):17-24. PubMed ID: 932248
[TBL] [Abstract][Full Text] [Related]
60. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?
van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM
Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
